Fundamental analysis · SEC EDGAR · TTM through 31/03/2026
GEHC · Nasdaq · Healthcare
Fundamental quality
51
out of 100
GE Healthcare Technologies Inc. earns a fundamental-quality score of 51 out of 100, profiling it as a company with demanding fundamentals. Its score rests mainly on its profitability (net margin 9.1%). Its weakest area is its growth (revenue +4.2%/yr). Whether it's cheap or expensive depends on the current price, which you can compute in the tool.
GE HealthCare, spun off from General Electric, makes the big medical-imaging machines: MRI, CT and ultrasound scanners plus patient monitoring, along with the contrast agents injected for scans. It is in radiology rooms across half the world.
EPS growth: -4% · Revenue growth: 4.2%
Net margin: 9.1% · ROE: 17.9% · ROIC: 10.9%
Net debt/EBITDA: 2.67x
Source: SEC EDGAR · TTM through 31/03/2026
The score combines growth, profitability and financial strength. Here its profitability weighs in its favor, while its growth drags it down the most.
Percentile against the other 57 Healthcare companies in our coverage: how far it beats them on each metric (100 = best in sector).
Computed from the daily dataset scores. A high percentile places the company among the best in its sector on that metric; it is not a buy recommendation.
Key concepts
What do these metrics mean? Fundamental analysis · What is the P/E · What is EPS · What is ROE · Net & gross margin · Free cash flow
| Year | Revenue | Net income | Free cash flow | Net debt |
|---|---|---|---|---|
| 2021 | 17,585 | 2,247 | — | -561 |
| 2022 | 18,341 | 1,916 | — | 6,801 |
| 2023 | 19,552 | 1,568 | — | 6,944 |
| 2024 | 19,672 | 1,993 | — | 6,075 |
| 2025 | 20,625 | 2,084 | — | 5,505 |
Between 2021 and 2025, revenue went from $17,585M to $20,625M (+17%) and net income went from $2,247M to $2,084M (-7%). Meanwhile, its margins have narrowed (from 13% to 10%).
Annual figures in millions of U.S. dollars ($M) per SEC filings. Net debt is total debt minus cash.
Latest results
Figures for the quarter ended March 31, 2026, versus the quarter ended March 31, 2025 (SEC filings):
Automatic comparison between the two most recent periods filed with the SEC. One quarter doesn't make a trend: read it alongside the historical evolution above.
$0.14
per share, yearly
3.1% of earnings
Payout
The dividend yield depends on today's price. Compute it in the analyzer → · See all dividend-paying stocks →
Open your account in minutes with regulated brokers and buy U.S. and European stocks from small amounts. No paperwork.
The serious investor's standard
Open free account →Anyone who wants low commissions and access to almost any market in the world.
Popular in the U.S.
Open free account →Anyone investing in the U.S. who wants a powerful, commission-free stock app.
Investing carries risk of loss.
Is GE Healthcare Technologies Inc. cheap or expensive?
That depends on the current price. Look it up, enter it in the tool and get the full valuation verdict (P/E against its sector).
Compute the valuation →Is GE Healthcare Technologies Inc. a good company to invest in?
In terms of business quality, GE Healthcare Technologies Inc. scores 51 out of 100 in our analysis, placing it as a company with demanding fundamentals. That said, this isn't a recommendation: whether it's a good investment also depends on its current price and your goals.
Is GE Healthcare Technologies Inc. a profitable company?
GE Healthcare Technologies Inc. is profitable, with a net margin of 9.1%, though a thin one.
Does GE Healthcare Technologies Inc. have a lot of debt?
A moderate level: its net debt is 2.67 times its EBITDA.
Is GE Healthcare Technologies Inc. growing?
Its revenue has grown 4.2% annualized in recent years, and without interruption since 2021.
The thresholds are general and the system doesn't judge qualitative factors. See the full methodology and use this analysis as a first filter, never as a final decision.
More Healthcare companies
Stryker (SYK) · Vertex Pharmaceuticals (VRTX) · Boston Scientific (BSX) · Medtronic (MDT) · Regeneron (REGN) · Bristol Myers Squibb (BMY) · see more →
The best Healthcare stocks by our model →
Compare GE Healthcare Technologies Inc. with 500+ companies in the screener →
Who's behind the methodology and model · how the score is computed
Data: see GE Healthcare Technologies Inc.'s filings on EDGAR
Spotted a figure that looks wrong? Report it and we'll review it.